Vir Biotechnology (VIR) Research & Development (2018 - 2026)
Vir Biotechnology's Research & Development was $80.04 million in Q3 2026, down 47.2% from $151.46 million a year earlier and down 40.8% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Research & Development (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vir Biotechnology's Research & Development was $412.59 million through Sep 30, 2026, down 12.9% year-over-year; for FY2025, it was $455.97 million, down 10.0% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
- In earlier years, Research & Development was $506.5 million in FY2024 (-12.6%), $579.72 million in FY2023 (+22.1%), $474.65 million in FY2022 (+5.9%) and $448.01 million in FY2021 (+48.1%).
- The Q3 2026 figure marks the lowest quarterly Research & Development since Q3 2020.
- Compared with a year earlier, Research & Development was higher in two of the last eight quarters, with an average decline of 5.9%.
- The best year-over-year quarter for Research & Development over five years was Q1 2023 (growth of 74.7%); the worst was Q3 2026 (a decline of 47.2%).
- Per Business Quant data, VIR's Research & Development in the three quarters before Q3 2026 was $135.28 million (Q2 2026), $108.92 million (Q1 2026) and $88.35 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Vir Biotechnology | 2.28 Bn | 363.84 Mn | 188,000.00 | 80.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 80.04 Mn |
| Jun 30, 2026 | 135.28 Mn |
| Mar 31, 2026 | 108.92 Mn |
| Dec 31, 2025 | 88.35 Mn |
| Sep 30, 2025 | 151.46 Mn |
| Jun 30, 2025 | 97.51 Mn |
| Mar 31, 2025 | 118.65 Mn |
| Dec 31, 2024 | 106.08 Mn |
| Sep 30, 2024 | 195.18 Mn |
| Jun 30, 2024 | 105.11 Mn |
| Mar 31, 2024 | 100.13 Mn |
| Dec 31, 2023 | 108.97 Mn |
| Sep 30, 2023 | 145.03 Mn |
| Jun 30, 2023 | 168.08 Mn |
| Mar 31, 2023 | 157.64 Mn |
| Dec 31, 2022 | 155.17 Mn |
| Sep 30, 2022 | 114.17 Mn |
| Jun 30, 2022 | 115.08 Mn |
| Mar 31, 2022 | 90.23 Mn |
| Dec 31, 2021 | 128.34 Mn |
API Access
Vir Biotechnology Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();